retatrutide and testosterone Trt Major alert over 'experimental drug

But even if what you read there sounds convincing, its not always medically accurate or helpful

This matters enormously because cardiovascular disease and kidney damage are the leading causes of morbidity and mortality in lupus

But even with promising data, it remains a research-stage option, not a standard clinic treatment

Patients should consult healthcare professionals for safe usage

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management

Research suggests that ceasing treatment results in regaining weight within 6-12 months, so sustainable changes in eating and activity are crucial